Generics BulletinStada has announced the appointment of Biogen’s former global head of biosimilars, Ian Henshaw, to become the German firm’s global head of Specialty, a division that includes biosimilars. The move com
Generics BulletinKey personnel moves are afoot at both Stada and Medicines for Europe, after Stephan Eder stepped down from his current roles as executive vice-president for Western Europe and Germany at Stada and pre
Generics BulletinStada has credited its Alvotech-partnered Uzpruvo (ustekinumab) European biosimilar rival to Stelara for driving up its sales in the first quarter of 2025. The German giant’s Specialty division – whic
Generics BulletinIf Stada is indeed set to announce an initial public offering in the coming days, then its latest results have been positioned as a strong enticement to invest in the firm, which says it is outperform